Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,011 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancer.
Yanagihara K, Yoshimura K, Niimi M, Yasuda H, Sasaki T, Nishimura T, Ishiguro H, Matsumoto S, Kitano T, Kanai M, Misawa A, Tada H, Teramukai S, Mio T, Fukushima M. Yanagihara K, et al. Among authors: fukushima m. Cancer Chemother Pharmacol. 2010 Oct;66(5):913-8. doi: 10.1007/s00280-009-1239-7. Epub 2010 Jan 13. Cancer Chemother Pharmacol. 2010. PMID: 20069422 Free article. Clinical Trial.
Quality-of-life evaluation for advanced non-small-cell lung cancer: a comparison between vinorelbine plus gemcitabine followed by docetaxel versus paclitaxel plus carboplatin regimens in a randomized trial: Japan Multinational Trial Organization LC00-03 (BRI LC03-01).
Kawahara M, Tada H, Tokoro A, Teramukai S, Origasa H, Kubota K, Shinkai T, Fukushima M, Furuse K. Kawahara M, et al. Among authors: fukushima m. BMC Cancer. 2011 Aug 17;11:356. doi: 10.1186/1471-2407-11-356. BMC Cancer. 2011. PMID: 21849041 Free PMC article. Clinical Trial.
Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03.
Teramukai S, Kitano T, Kishida Y, Kawahara M, Kubota K, Komuta K, Minato K, Mio T, Fujita Y, Yonei T, Nakano K, Tsuboi M, Shibata K, Furuse K, Fukushima M. Teramukai S, et al. Among authors: fukushima m. Eur J Cancer. 2009 Jul;45(11):1950-8. doi: 10.1016/j.ejca.2009.01.023. Epub 2009 Feb 21. Eur J Cancer. 2009. PMID: 19231158 Free article. Clinical Trial.
Expression of thymidylate synthase in human non-small cell lung cancer.
Otake Y, Tanaka F, Yanagihara K, Hitomi S, Okabe H, Fukushima M, Wada H. Otake Y, et al. Among authors: fukushima m. Jpn J Cancer Res. 1999 Nov;90(11):1248-53. doi: 10.1111/j.1349-7006.1999.tb00704.x. Jpn J Cancer Res. 1999. PMID: 10622537 Free PMC article.
2,011 results